J H Davies|S J Whitaker - JoVE Visualize

Showing results (41-50 of 63) with videos related to

Pageof 7

Sort By:

The Journal of Clinical Endocrinology and Metabolism|December 13, 2003

Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from childrenJ H Davies, B A J Evans, M E M Jenney, et al.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 8, 2009

Basal cell carcinoma of the nipple-areola complexMark S Ferguson, S A Reza Nouraei, Ben J H Davies, et al.

Calcified Tissue International|June 11, 2002

In vitro effects of chemotherapeutic agents on human osteoblast-like cellsJ H Davies, B A J Evans, M E M Jenney, et al.

Bone|August 2, 2002

In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancyJ H Davies, B A J Evans, M E M Jenney, et al.

Journal of Neurosurgery|September 1, 1985

Fluid balance and secretion of antidiuretic hormone following transsphenoidal pituitary surgery. A preliminary seriesS J Whitaker, C I Meanock, G F Turner, et al.

British Journal of Cancer|July 1, 1992

Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancerJ H Davies, M Dowsett, S Jacobs, et al.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010

Reduced cortical bone density with normal trabecular bone density in girls with Turner syndromeC R Holroyd, J H Davies, P Taylor, et al.

British Journal of Urology|August 1, 1986

Metabolic consequences of forced diuresis following prostatectomyP R Malone, J H Davies, N J Standfield, et al.

British Journal of Cancer|August 1, 1990

Aromatase inhibition in advanced prostatic cancer: preliminary communicationR J Shearer, J H Davies, M Dowsett, et al.

Journal of Enzyme Inhibition|January 1, 1992

Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.

Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:

Pageof 7

The Journal of Clinical Endocrinology and Metabolism|December 13, 2003

Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from childrenJ H Davies, B A J Evans, M E M Jenney, et al.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 8, 2009

Basal cell carcinoma of the nipple-areola complexMark S Ferguson, S A Reza Nouraei, Ben J H Davies, et al.

Calcified Tissue International|June 11, 2002

In vitro effects of chemotherapeutic agents on human osteoblast-like cellsJ H Davies, B A J Evans, M E M Jenney, et al.

Bone|August 2, 2002

In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancyJ H Davies, B A J Evans, M E M Jenney, et al.

Journal of Neurosurgery|September 1, 1985

Fluid balance and secretion of antidiuretic hormone following transsphenoidal pituitary surgery. A preliminary seriesS J Whitaker, C I Meanock, G F Turner, et al.

British Journal of Cancer|July 1, 1992

Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancerJ H Davies, M Dowsett, S Jacobs, et al.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010

Reduced cortical bone density with normal trabecular bone density in girls with Turner syndromeC R Holroyd, J H Davies, P Taylor, et al.

British Journal of Urology|August 1, 1986

Metabolic consequences of forced diuresis following prostatectomyP R Malone, J H Davies, N J Standfield, et al.

British Journal of Cancer|August 1, 1990

Aromatase inhibition in advanced prostatic cancer: preliminary communicationR J Shearer, J H Davies, M Dowsett, et al.

Journal of Enzyme Inhibition|January 1, 1992

Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.

Pageof 7